Medprin Regenerative Medical Technologies Co., Ltd. announced that at the Annual General Meeting held on 12 May 2022, approved cash dividend (tax included) of CNY 1.00000000 per ten shares for 2021.
Medprin Regenerative Medical Technologies Co., Ltd.
Equities
301033
CNE100004NB8
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.74 CNY | +4.17% |
|
+5.57% | -6.43% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.43% | 356M | |
+12.37% | 130B | |
-9.54% | 10.81B | |
-17.40% | 7.12B | |
+47.72% | 6.46B | |
-31.81% | 3.98B | |
+8.15% | 3.43B | |
-20.83% | 2.48B | |
-18.87% | 1.91B | |
-25.13% | 1.66B |
- Stock Market
- Equities
- 301033 Stock
- News Medprin Regenerative Medical Technologies Co., Ltd.
- Medprin Regenerative Medical Technologies Co., Ltd. Approves Profit Distribution Plan for 2021